PEMED is a unique occasion to acquire up-to-date knowledge in the field of precision medicine and pharmacogenomics, focusing on technologies such as genomics, single cell sequencing, microbiome analysis and transcriptomics as well as bioinformatics and digital innovations.
SCHEDULE OVERVIEW
Schedule overview (CET)
- 9 AM
- 9:10 AM
- 9:45 AM
- 10:20 AM
- 10:55 AM
- 11:15 AM
- 11:50 AM
- 12:25 PM
- 1:30 PM
- 2:05 PM
- 2:40 PM
- 3:00 PM
- 3:35 PM
- 4:10-4:45 PM
April 7, 2021
- Opening Ceremony
- Prof.Alberto Bardelli
High dose Vitamin C and inactivation of DNA repair boost cancer immunotherapy - Mr. Åslaug Helland
Implementing precision cancer medicine in Norway – IMPRESS-Norway - Mr. Hege Russnes
Establishing an infrastructure for precision diagnostics, cancer - Break
- Prof. Manel Esteller
Epigenetics and Epitranscriptomics of Human Cancer: From Knowledge to Applications - Stefan M Pfister
Personalized Pediatric Oncology – Promises and Challenges - Lunch
- Mingzhou Guo
A novel synthetic lethal strategy: targeting DNA damage repair based on epigenetic defects - Montse Sanchez-Cespedes
Determinants of immunological evasion and immune checkpoint inhibition response: the genetic front - Break
- Qian Zhang
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 - Elaine S. Jaffe
Lymphoma Diagnosis and Discovery as a Basis for Personalized Medicine - Ari M. Melnick
Coming soon
Schedule overview (CET)
- 9:00 AM
- 9:35 AM
- 10:10 AM
- 10:45 AM
- 11:05 AM
- 12:50 PM
- 2:00 PM
- 2:30 PM
- 3:00-3:15 PM
April 9, 2021
- Prof. Maria Jose Alonso
Pharmaceutical Nanotechnology and Precision Nanomedicine: New oncological treatments - Ms. Julià Blanco
A new standard for science - Mr. Paul Bastard
Auto-antibodies against type I interferons in patients with life-threatening COVID-19. - Break
- Oral Session
- Lunch
- Flash Session 1
- Flash Session 2
- Closing Session
Schedule overview (CET)
- 9:00 AM
- 9:35 AM
- 10:10 AM
- 10:30 AM
- 11:05 AM
- 11:40 AM
- 1:00 PM
- 1:35 PM
- 2:10 PM
- 2:45 PM
- 3:05 PM
- 3:40-4:30 PM
April 8, 2021
- Prof. Matthias Schwab
PharmacoOmics and renal cancer - Prof. Ann K. Daly
Genetics of drug-induced liver injury: relevance of non-HLA risk factors - Break
- Dr. Anne-Marie Caminade
Dendrimers: emerging opportunities for bioimaging and diagnosis - Mr. Kari Stefansson
Human diversity in the context of health and disease - Lunch
- Mr. Julio Saez-Rodriguez
Patient-specific network models for personalized medicine - Mr. Eduard Porta
Bridging the gap across biological scales in cancer - Mr. Emmanouil Dermitzakis
Dissecting disease mechanisms with genetically perturbed regulatory networks - Break
- Mr. Amos Tanay
Modelling health, ageing and disease trajectories in electronic health records - Dr. Olivier Elemento
Coming soon